BridgeMD
LASER volunteer trial: Local Anaesthetic Systemic Effect during Regional anaesthesia procedures
EU CTIS ID: 2025-520910-67-01
What this study is testing
To prove superior systemic analgesic effect of lidocaine and ropivacaine after a fascial plane block (TAP block) using an electrical experimental pain model on the area of hyperalgesia.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Participant must be 18 to 64 years of age inclusive, at the time of signing the informed consent
- Participants who are overtly healthy as determined by medical evaluation (medical history, use of medications, subjective physical impairments) prior to participation in the study. Participants must have ASA physical Status Classification 1 or 2.
- Body weight within the range of 60 to 95 kg (inclusive) and BMI within the range of 18 to 35 kg/m2 (inclusive)
- Male participants
- Capable of giving signed informed consent
You likely can't join if
- Neurologic disease, nerve- or vascular impairment
- Known coagulopathy
- Allergic to local anaesthetic agents
- Skin infection or exanthema at the site for TAP block or the sites involved in sensory testing
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.